Phenotypic vs. target-based drug discovery for first-in-class medicines

Area of Science:

• Drug discovery and development
• Medicinal chemistry
• Pharmacology

Background:

• Current drug discovery employs molecular (target-based) and empirical (phenotypic) strategies.
• Target-based approaches are hypothesis-driven.
• Phenotypic approaches rely on observable responses.

Purpose of the Study:

• To analyze the success rates of different drug discovery strategies.
• To identify factors contributing to the success of phenotypic approaches.
• To understand the role of unbiased mechanism identification in drug development.

Main Methods:

• Review and analysis of existing drug discovery methodologies.
• Comparison of success rates for target-based versus phenotypic strategies.
• Investigation into the rationalization behind phenotypic approach success.

Main Results:

• Phenotypic approaches demonstrate greater success in identifying first-in-class small-molecule medicines.
• The unbiased identification of the molecular mechanism of action (MMOA) is a key factor in this success.
• Analysis suggests a shift towards prioritizing phenotypic screening for novel therapeutics.

Conclusions:

• Phenotypic drug discovery is a highly effective strategy for identifying novel small-molecule therapeutics.
• Unbiased identification of the molecular mechanism of action (MMOA) is crucial for successful drug development.
• The findings support the continued use and optimization of phenotypic approaches in medicinal chemistry.